Retroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer

Amir Hosseini1, Håvard T Lindholm2, Raymond Chen3

  • 1Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, UK.

Cell Reports
|January 23, 2024
PubMed

Insights

Viral mimicry, triggered by endogenous double-stranded RNA (dsRNA), can be exploited to target cancer. Researchers found the RNA decay protein XRN1 is essential for survival in some cancer cells, suggesting it as a therapeutic target.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Viral mimicry involves immune responses to endogenous stimuli like double-stranded RNA (dsRNA).
  • Activating viral mimicry shows potential for cancer cell death and enhanced anti-tumor immunity.

Purpose of the Study:

  • To systematically identify mechanisms of viral mimicry adaptation linked to cancer cell dependencies.
  • To explore the role of the RNA decay protein XRN1 in cancer cell survival and viral mimicry.

Main Methods:

  • Systematic identification of cancer cell dependencies related to viral mimicry.
  • Analysis of XRN1 dependency, mitochondrial antiviral signaling (MAVS), and protein kinase R (PKR) activation.
  • Quantification of cytosolic dsRNA, Alu elements, and interferon-stimulated gene expression.
  • Investigating the effects of dsRNA-inducing drugs (5-aza-2'-deoxycytidine, palbociclib) on XRN1 dependency.

Main Results:

  • XRN1 was identified as an essential gene for the survival of a subset of cancer cell lines.
  • XRN1 dependency is linked to MAVS and PKR activation, increased cytosolic dsRNA, and elevated interferon-stimulated gene expression.
  • Cancer cells exhibiting these characteristics die due to induced viral mimicry.
  • dsRNA-inducing drugs created a synthetic dependency on XRN1 in resistant cancer cells.

Conclusions:

  • XRN1 is crucial for cancer cell survival under conditions of induced viral mimicry.
  • The interplay between XRN1, dsRNA, and innate immune signaling pathways is key to this dependency.
  • Targeting XRN1, potentially in combination with dsRNA-inducing agents, represents a promising therapeutic strategy for cancer treatment.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.3K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K